Bridgeway Capital Management’s Sagimet Biosciences SGMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.15M | Buy |
412,841
+288,341
| +232% | +$2.2M | 0.07% | 371 |
|
|
2025
Q1 | $406K | Sell |
124,500
-99,600
| -44% | -$325K | 0.01% | 781 |
|
|
2024
Q4 | $1.01M | Buy |
224,100
+85,800
| +62% | +$386K | 0.02% | 670 |
|
|
2024
Q3 | $383K | Buy |
138,300
+93,300
| +207% | +$258K | 0.01% | 924 |
|
|
2024
Q2 | $154K | Hold |
45,000
| – | – | ﹤0.01% | 1107 |
|
|
2024
Q1 | $244K | Hold |
45,000
| – | – | 0.01% | 1071 |
|
|
2023
Q4 | $244K | Buy |
+45,000
| New | +$244K | 0.01% | 1096 |
|